Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs55695515 | chr8:121420087 | T/C | 4.06E-6 | 177 | 27.2 | 25.67 | 19.87 | KM Plot |
PCPG | rs55697150 | chr2:61590612 | A/G | 6.44E-5 | 177 | 24.1 | 30.93 | 10.3 | KM Plot |
PCPG | rs55700120 | chr7:105148460 | G/T | 5.04E-5 | 178 | 20.17 | 28.95 | 2.28 | KM Plot |
PCPG | rs55701318 | chr7:105175738 | G/A | 7.98E-5 | 171 | 20.2 | 29.88 | 2.28 | KM Plot |
PCPG | rs55706607 | chr2:61595504 | T/C | 7.12E-5 | 175 | 24.3 | 29.88 | 10.3 | KM Plot |
PCPG | rs55715412 | chr22:21293974 | TAA/T | 7.74E-5 | 177 | 12.93 | 31.47 | 25.2 | KM Plot |
PCPG | rs55740553 | chr7:105159551 | A/G | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs55750405 | chr11:18160457 | G/A | 4.87E-6 | 172 | 26.53 | 21.78 | 8.33 | KM Plot |
PCPG | rs55760111 | chr3:195724449 | C/T | 1.53E-5 | 175 | 24.5 | 32.92 | 13.38 | KM Plot |
PCPG | rs55765119 | chr10:29846944 | A/G | 3.99E-11 | 178 | 25.53 | 22.05 | 10.3 | KM Plot |
PCPG | rs55778373 | chr21:38573246 | G/A | 1.11E-16 | 175 | 24.85 | 25.63 | 3.17 | KM Plot |
PCPG | rs55794529 | chr7:105165747 | T/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs55801944 | chr4:110973113 | C/G | 0 | 175 | 26.88 | 18.93 | 2.93 | KM Plot |
PCPG | rs55807365 | chr16:1667083 | C/A | 0 | 175 | 25.53 | 27.33 | 2.93 | KM Plot |
PCPG | rs55808121 | chr2:236194046 | T/C | 2.27E-7 | 175 | 25.97 | 25.05 | 3.07 | KM Plot |